| Sep 20 |
AstraZeneca's FluMist nasal spray vaccine approved for self-administration
|
| Sep 20 |
US FDA approves AstraZeneca's self-administered nasal spray flu vaccine
|
| Sep 20 |
AstraZeneca (LSE:AZN) Gains FDA Approval for Fasenra in EGPA, Boosting Revenue Growth and Market Position
|
| Sep 19 |
AstraZeneca’s Fasenra to challenge GSK’s Nucala in rare vasculitis after FDA nod
|
| Sep 19 |
Wall Street Bulls Look Optimistic About Astrazeneca (AZN): Should You Buy?
|
| Sep 19 |
AstraZeneca’s Fasenra meets primary endpoint in Phase III rare vasculitis trial
|
| Sep 19 |
2 Unstoppable S&P 500 Dividend Stocks to Buy Before They Beat the Market Again
|
| Sep 19 |
Could The Market Be Wrong About AstraZeneca PLC (LON:AZN) Given Its Attractive Financial Prospects?
|
| Sep 18 |
AstraZeneca Fasenra gains additional indication
|
| Sep 18 |
AZN Gets FDA Nod for Fasenra Label Expansion in Rare Disease
|
